Literature DB >> 23126020

Canadian Guidelines on Parkinson's Disease.

David Grimes1, Joyce Gordon, Barbara Snelgrove, Ivy Lim-Carter, Edward Fon, Wayne Martin, Marguerite Wieler, Oksana Suchowersky, Alex Rajput, Anne L Lafontaine, Jon Stoessl, Elena Moro, Kerrie Schoffer, Janis Miyasaki, Doug Hobson, Minoo Mahmoudi, Susan Fox, Ron Postuma, Hrishikesh Kumar, Mandar Jog.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23126020     DOI： 10.1017/s031716710001516x

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN： 0317-1671            Impact factor:   2.104


× No keyword cloud information.
  27 in total

1.  Practice recommendations for Parkinson's disease: Assessment and management by community pharmacists.

Authors:  Tejal Patel; Feng Chang
Journal:  Can Pharm J (Ott)       Date:  2015-05

2.  Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.

Authors:  C L Gregson; E M Dennison; J E Compston; S Adami; J D Adachi; F A Anderson; S Boonen; R Chapurlat; A Díez-Pérez; S L Greenspan; F H Hooven; A Z LaCroix; J W Nieves; J C Netelenbos; J Pfeilschifter; M Rossini; C Roux; K G Saag; S Silverman; E S Siris; N B Watts; A Wyman; C Cooper
Journal:  Osteoporos Int       Date:  2013-07-25       Impact factor: 4.507

3.  Modafinil: Parkinson disease-related somnolence.

Authors:  Joyce A Generali; Dennis J Cada
Journal:  Hosp Pharm       Date:  2014-07

4.  Parkinson's disease guidelines for pharmacists.

Authors:  Tejal Patel; Feng Chang
Journal:  Can Pharm J (Ott)       Date:  2014-05

Review 5.  An update on the diagnosis and treatment of Parkinson disease.

Authors:  Philippe Rizek; Niraj Kumar; Mandar S Jog
Journal:  CMAJ       Date:  2016-05-24       Impact factor: 8.262

6.  Frequency of and risk factors for potentially inappropriate medication use in Parkinson's disease.

Authors:  Danielle S Abraham; Thanh Phuong Pham Nguyen; Sean Hennessy; Daniel Weintraub; Shelly L Gray; Dawei Xie; Allison W Willis
Journal:  Age Ageing       Date:  2020-08-24       Impact factor: 10.668

7.  Pharmacological management of neuropsychiatric symptoms in patients with major neurocognitive disorders.

Authors:  Dominique Elie; Soham Rej
Journal:  J Psychiatry Neurosci       Date:  2018-01       Impact factor: 6.186

8.  Streamlining the management of Parkinson disease in Canada.

Authors:  Veronica Bruno; Maria Eliza Thomaz de Freitas
Journal:  CMAJ       Date:  2019-09-09       Impact factor: 8.262

9.  Canadian guideline for Parkinson disease.

Authors:  David Grimes; Megan Fitzpatrick; Joyce Gordon; Janis Miyasaki; Edward A Fon; Michael Schlossmacher; Oksana Suchowersky; Alexander Rajput; Anne Louise Lafontaine; Tiago Mestre; Silke Appel-Cresswell; Suneil K Kalia; Kerrie Schoffer; Mateusz Zurowski; Ronald B Postuma; Sean Udow; Susan Fox; Pauline Barbeau; Brian Hutton
Journal:  CMAJ       Date:  2019-09-09       Impact factor: 8.262

10.  Compliance with pharmacotherapy and direct healthcare costs in patients with Parkinson's disease: a retrospective claims database analysis.

Authors:  Florent F Richy; Guilhem Pietri; Kimberly A Moran; Emmanuelle Senior; Lydia E Makaroff
Journal:  Appl Health Econ Health Policy       Date:  2013-08       Impact factor: 2.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.